| Nicholas Adam Spendlove, MD | |
|
1124 10th St, Alamogordo, NM 88310-6414 | |
| (806) 743-1000 | |
| Not Available |
| Full Name | Nicholas Adam Spendlove |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 6 Years |
| Location | 1124 10th St, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083111454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD2022-0364 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fillmore Eye Clinic Incorporated | 7214069293 | 12 |
News Archive
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
Recently published research from Iowa State University may hint at a new treatment for Parkinson's disease.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
› Verified 2 days ago
| Entity Name | Fillmore Eye Clinic Incorporated |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1487657862 PECOS PAC ID: 7214069293 Enrollment ID: O20100712000237 |
News Archive
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
Recently published research from Iowa State University may hint at a new treatment for Parkinson's disease.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
› Verified 2 days ago
| Entity Name | Fillmore Eye Clinic Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083931182 PECOS PAC ID: 7214069293 Enrollment ID: O20100920000994 |
News Archive
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
Recently published research from Iowa State University may hint at a new treatment for Parkinson's disease.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Adam Spendlove, MD 1124 10th St, Alamogordo, NM 88310-6414 Ph: (575) 434-1200 | Nicholas Adam Spendlove, MD 1124 10th St, Alamogordo, NM 88310-6414 Ph: (806) 743-1000 |
News Archive
The results of Olympus' ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists' workloads were announced at the Japan Society of Digital Pathology Study annual meeting.
Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
Recently published research from Iowa State University may hint at a new treatment for Parkinson's disease.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
› Verified 2 days ago
William Alton Bohart, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1124 10th St, Alamogordo, NM 88310 Phone: 575-434-1200 Fax: 575-437-3947 | |
Parley D Fillmore, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1124 10th St, Alamogordo, NM 88310 Phone: 575-434-1200 Fax: 575-437-3947 | |
Michelle Yang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 923 Ninth St, Ste B, Alamogordo, NM 88310 Phone: 505-437-9900 Fax: 505-437-5500 |